UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.071

Sortiert nach

High Mobility Group Box‐1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice

Hepatology (Baltimore, Md.), 2018-12, Vol.68 (6), p.2380-2404

2018

Volltextzugriff (PDF)

Mechanistic biomarkers provide early and sensitive detection of acetaminophen‐induced acute liver injury at first presentation to hospital

Hepatology (Baltimore, Md.), 2013-08, Vol.58 (2), p.777-787

2013

Volltextzugriff (PDF)

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis

The Journal of clinical investigation, 2018-06, Vol.128 (6), p.2436-2451

2018

Volltextzugriff (PDF)

HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients

Clinical cancer research, 2016-06, Vol.22 (12), p.3087-3096

2016

Volltextzugriff (PDF)

Circulating microRNAs as potential markers of human drug‐induced liver injury

Hepatology (Baltimore, Md.), 2011-11, Vol.54 (5), p.1767-1776

2011

Volltextzugriff (PDF)

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis

The Journal of clinical investigation, 2019-03, Vol.130 (4), p.1802-1802

2019

Volltextzugriff (PDF)

A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins

Molecular medicine (Cambridge, Mass.), 2014-01, Vol.20 (1), p.135-137

2014

Volltextzugriff (PDF)

Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study

PloS one, 2012-08, Vol.7 (8), p.e43809

2012

Volltextzugriff (PDF)

Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423

Toxicological sciences, 2016-07, Vol.152 (1), p.205-213

2016

Volltextzugriff (PDF)

Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?

Expert opinion on drug safety, 2016-05, Vol.15 (5), p.625-634

2016

Volltextzugriff (PDF)

Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts

Liver international, 2014-03, Vol.34 (3), p.367-378

2014

Volltextzugriff (PDF)

Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Molecular medicine (Cambridge, Mass.), 2020-12, Vol.26 (1), p.131-131, Article 131

2020

Volltextzugriff (PDF)

Retraction Note: The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function

Molecular medicine (Cambridge, Mass.), 2020-12, Vol.26 (1), p.132-132, Article 132

2020

Volltextzugriff (PDF)

Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Molecular medicine (Cambridge, Mass.), 2020-12, Vol.26 (1), p.133-133, Article 133

2020

Volltextzugriff (PDF)

Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis

Antioxidants & redox signaling, 2016-04, Vol.24 (12), p.605

2016

Volltextzugriff (PDF)

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Molecular medicine (Cambridge, Mass.), 2020-02, Vol.26 (1), p.1-1, Article 17

2020

Volltextzugriff (PDF)

Expression of Concern to: The α7 nicotine acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function

Molecular medicine (Cambridge, Mass.), 2020-02, Vol.26 (1), p.16-16, Article 16

2020

Volltextzugriff (PDF)

High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Molecular medicine (Cambridge, Mass.), 2014, Vol.20 (1), p.538-547

2014

Volltextzugriff (PDF)

Expression of Concern to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Molecular medicine (Cambridge, Mass.), 2020-02, Vol.26 (1), p.18-18, Article 18

2020

Volltextzugriff (PDF)

Aminoglycoside-induced nephrotoxicity in children

Pediatric nephrology (Berlin, West), 2017-11, Vol.32 (11), p.2015-2025

2017

Volltextzugriff (PDF)

Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes

JCI insight, 2016-05, Vol.1 (7)

2016

Volltextzugriff (PDF)

Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature

European journal of clinical pharmacology, 2018-02, Vol.74 (2), p.147-160

2018

Volltextzugriff (PDF)

Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity

Journal of hepatology, 2012-01, Vol.56 (5), p.1070-1079

2012

Volltextzugriff (PDF)

Development of mechanism-based novel DILI biomarkers and therapeutic interventions

Drug metabolism and pharmacokinetics, 2018-01, Vol.33 (1), p.S7-S8

Antoine, Daniel J.

2018

Volltextzugriff (PDF)

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis

The Journal of clinical investigation, 2019-04, Vol.129 (4), p.1803-1803

2019

Volltextzugriff (PDF)

1 – 25 von 1.071

Suche als RSS-Feed

Aktive Filter

ThemaAnimals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(836)
Mit Volltextzugriff
(972)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(22)

Menü

Weitere Dienste

Einstellungen

High Mobility Group Box‐1 Drives Fibrosis Progression Signaling via the Receptor for Advanced Glycation End Products in Mice

Mechanistic biomarkers provide early and sensitive detection of acetaminophen‐induced acute liver injury at first presentation to hospital

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis

HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients

Circulating microRNAs as potential markers of human drug‐induced liver injury

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis

A systematic nomenclature for the redox states of high mobility group box (HMGB) proteins

Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study

Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423

Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?

Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts

Retraction Note to: High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Retraction Note: The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function

Retraction Note to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis

Expression of concern to: High systematic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Expression of Concern to: The α7 nicotine acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function

High systemic levels of the cytokine-inducing HMGB1 isoform secreted in severe macrophage activation syndrome

Expression of Concern to: Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

Aminoglycoside-induced nephrotoxicity in children

Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes

Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature

Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity

Development of mechanism-based novel DILI biomarkers and therapeutic interventions

HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis

Aktive Filter

Suchergebnisse filtern